Clinical trial
Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI
NCT06945822 is registered in ClinicalTrials.gov with Institut Pasteur as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI
- Lead sponsor
- Institut Pasteur
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 1, 2025
- Completion date
- July 1, 2029
- Enrollment
- 450 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.